State immunity and arbitration in China
Produced in partnership with Fangda Partners
Practice notesState immunity and arbitration in China
Produced in partnership with Fangda Partners
Practice notesThis Practice Note summarises the position taken by the People's Republic of China (PRC) (China) on state immunity. For a general introduction to state immunity and Arbitration, see Practice Note: State immunity and arbitration—general considerations. For Practice Notes on state immunity in a number of jurisdictions around the world (including England and Wales), see our ‘State immunity’ subtopic: State immunity and arbitration—overview.
Note: Chinese and Hong Kong court judgments referred to in this Practice Note are not reported by LexisNexis® UK.
Note : this Practice Note is currently under review by its authors in light of the adoption by China of the Foreign State Immunity Law (FSIL), which took effect from 1 January 2024, and which has moved China from the doctrine of absolute immunity to the doctrine of restricted immunity as far as foreign states are concerned.
State immunity—definition, concepts and approaches
State immunity (often referred to as sovereign immunity) is a concept of public international law that describes relationships involving sovereign states, often invoked by states or state-owned enterprises (SOEs) in jurisdictional challenges
To view the latest version of this document and thousands of others like it,
sign-in with LexisNexis or register for a free trial.